Wegesser TC - Search Results

1

California wildfires of 2008: coarse and fine particulate matter toxicity.

Wegesser TC, Pinkerton KE, Last JA. Wegesser TC, et al. Environ Health Perspect. 2009 Jun;117(6):893-7. doi: 10.1289/ehp.0800166. Epub 2009 Feb 2. Environ Health Perspect. 2009. PMID: 19590679 Free PMC article.

2

Lung response to coarse PM: bioassay in mice.

Wegesser TC, Last JA. Wegesser TC, et al. Toxicol Appl Pharmacol. 2008 Jul 15;230(2):159-66. doi: 10.1016/j.taap.2008.02.013. Epub 2008 Feb 26. Toxicol Appl Pharmacol. 2008. PMID: 18384828 Free PMC article.

3

Mouse lung inflammation after instillation of particulate matter collected from a working dairy barn.

Wegesser TC, Last JA. Wegesser TC, et al. Toxicol Appl Pharmacol. 2009 May 1;236(3):348-57. doi: 10.1016/j.taap.2009.02.023. Epub 2009 Mar 9. Toxicol Appl Pharmacol. 2009. PMID: 19272399 Free PMC article.

4

Lung antioxidant and cytokine responses to coarse and fine particulate matter from the great California wildfires of 2008.

Wegesser TC, Franzi LM, Mitloehner FM, Eiguren-Fernandez A, Last JA. Wegesser TC, et al. Inhal Toxicol. 2010 Jun;22(7):561-70. doi: 10.3109/08958370903571849. Inhal Toxicol. 2010. PMID: 20388000

5

Fine particulate matter from urban ambient and wildfire sources from California's San Joaquin Valley initiate differential inflammatory, oxidative stress, and xenobiotic responses in human bronchial epithelial cells.

Nakayama Wong LS, Aung HH, Lamé MW, Wegesser TC, Wilson DW. Nakayama Wong LS, et al. Among authors: wegesser tc. Toxicol In Vitro. 2011 Dec;25(8):1895-905. doi: 10.1016/j.tiv.2011.06.001. Epub 2011 Jun 15. Toxicol In Vitro. 2011. PMID: 21703343

6

In vivo effects of ozone exposure on protein adduct formation by 1-nitronaphthalene in rat lung.

Wheelock AM, Boland BC, Isbell M, Morin D, Wegesser TC, Plopper CG, Buckpitt AR. Wheelock AM, et al. Among authors: wegesser tc. Am J Respir Cell Mol Biol. 2005 Aug;33(2):130-7. doi: 10.1165/rcmb.2005-0047OC. Epub 2005 Apr 21. Am J Respir Cell Mol Biol. 2005. PMID: 15845863 Free PMC article.

7

Nonclinical genotoxicity and carcinogenicity profile of apremilast, an oral selective inhibitor of PDE4.

Wegesser T, Coppi A, Harper T Jr, Paris M, Minocherhomji S. Wegesser T, et al. Regul Toxicol Pharmacol. 2021 Oct;125:104985. doi: 10.1016/j.yrtph.2021.104985. Epub 2021 Jul 5. Regul Toxicol Pharmacol. 2021. PMID: 34237378 Free article.

8

Characterization of false positive, contaminant-driven mutagenicity in impurities associated with the sotorasib drug substance.

Coppi A, Davies R, Wegesser T, Ishida K, Karmel J, Han J, Aiello F, Xie Y, Corbett MT, Parsons AT, Monticello TM, Minocherhomji S. Coppi A, et al. Regul Toxicol Pharmacol. 2022 Jun;131:105162. doi: 10.1016/j.yrtph.2022.105162. Epub 2022 Mar 21. Regul Toxicol Pharmacol. 2022. PMID: 35331777

9

Harmonized 3Rs-based non-mutagenic impurity qualification study designs developed using the results of an IQ consortium survey.

Mitra MS, Datta K, Hutchinson R, Nicolette JJ, Pettersen JC, Wegesser TC, Bercu JP. Mitra MS, et al. Among authors: wegesser tc. Regul Toxicol Pharmacol. 2021 Jun;122:104895. doi: 10.1016/j.yrtph.2021.104895. Epub 2021 Feb 19. Regul Toxicol Pharmacol. 2021. PMID: 33610610

10

Strategies to evaluate potential effector function of glycan variants: a case study of ordesekimab (AMG 714 or PRV-015).

Wei YL, Wegesser T, Kuhns S, Werner J, Lebrec H, Wang X. Wei YL, et al. J Immunotoxicol. 2022 Dec;19(1):109-116. doi: 10.1080/1547691X.2022.2113841. J Immunotoxicol. 2022. PMID: 36083248 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page